Upgrading from ventricular to physiological pacing: is it worth it?

1997; 77: 273–5. [32] Natale A, Beheiry S, Wase A et al. Occurrence of clinical asystole in patients without evidence of structural heart disease: response to tilt test and follow-up. Circulation 1999; 100: I-245. [33] Fitzpatrick A, Sutton R. Tilting towards a diagnosis in recurrent unexplained syncope. Lancet 1989; 1: 658–60. [34] Strasberg B, Rechavia E, Sagie A et al. The head-up tilt table test in patients with syncope of unknown origin. Am Heart J 1989; 118: 923–6. [35] Jaeger F, Schneider L, Maloney J, Cruse R, Fouad-Tarazi F. Vasovagal syncope: diagnostic role of head-up tilt test in patients with positive ocular compression test. PACE 1990; 13: 1416–23. [36] Pongiglione G, Fish F, Strasburger J, Benson W. Heart rate and blood pressure response to upright tilt in young patients with unexplained syncope. J Am Coll Cardiol 1990; 16: 165–70. [37] Sra J, Anderson A, Sheikh S et al. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Int Med 1991; 144: 1013–9. [38] Brignole M, Menozzi C, Gianfranchi L, Oddone D, Lolli G, Bertulla A. Carotid sinus massage, eyeball compression, and head-up tilt test in patients with syncope of uncertain origin and healthy control subjects. Am Heart J 1991; 122: 1644–51. [39] Cicogna R, Bonomi F, Mascioli G et al. Profilo emodinamico e neuroendocrino di due distinte risposte cardiovascolari nella sincope vasodepressiva indotta da head-up tilt test. G Ital Cardiol 1992; 22: 1367–79. [40] Raviele A, Gasparini G, Di Pede F et al. Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. Am Heart J 1994; 127: 103–11. [41] Aerts A, Dendale P, Strobel G, Block P. Sublingual nitrates during head-up tilt testing for the diagnosis of vasovagal syncope. Am Heart J 1997; 133: 504–7. [42] Ammirati F, Colivicchi F, Biffi A, Magris B, Pandozi C, Santini M. Head-up tilt testing potentiated with low-dose sublingual isosorbide dinitrate: a simplified time-saving approach for the evaluation of unexplained syncope. Am Heart J 1998; 135: 671–6. [43] Aerts AJ, Dendale P, Daniels C et al. Intravenous nitrates for pharmacological stimulation during head-up tilt testing in patients with suspected vasovagal syncope and healthy controls. PACE 1999; 22: 1593–8. [44] Van de Walle J, Panagides D, Messier M et al. Tilt table testing of young adult patients: improved speed and sensitivity using an isoproterenol bolus and a continuous 60 tilt. PACE 1998; 21: 494–8. [45] Foglia-Manzillo G, Giada F, Beretta S, Corrado G, Santarone M, Raviele A. Reproducibility of head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. Am J Cardiol 1999; 84: 284–8. [46] Menozzi C, Brignole M, Lolli G et al. Follow-up of asystolic episodes in patients with cardioinhibitory, neurally mediated syncope and VVI pacemaker. Am J Cardiol 1993; 72: 1152–5. [47] Moya A, Brignole M, Menozzi C et al. Mechanism of syncope in patients with isolated syncope and in patients with tiltpositive syncope. Circulation 2001; 104: 1261–7. [48] Kurbaan A, Franzen A, Heaven D et al. Cardioinhibition during tilt testing identifies patients who may benefit from pacing. PACE 2000; 23: 1792–4. [49] Connolly S, Sheldon R, Roberts R, Gent M. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33: 16–20. [50] Sutton R, Brignole M, Menozzi C et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: a multicenter randomized study. Circulation 2001; 102: 294–9. [51] Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. Circulation 2001; 104: 52–7. [52] Benditt D. Cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33: 21–3.